Hepatocyte-specific Smad4 deletion in mice reduced liver tumors, fibrosis, and myeloid-derived suppressor cell infiltration while enhancing anti-tumor immunity (Xin et al., 2024). The gene discussed is SMAD4; the disease is neoplasm.